Posts

Showing posts with the label hepatitis delta virus

Hepatitis Delta (HDV) Virus - Pipeline Review, H2 2018 – Pharmaceutical and Healthcare Market Research

Image
Summary Latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis D - Pipeline Review, H2 2018 , provides comprehensive information on the therapeutics under development for Hepatitis D (Infectious Disease), mechanism of action (MoA), route of administration (RoA) and molecule type. It covers the descriptive pharmacological action of the therapeutics Report Highlights Hepatitis D - Companies Involved in Therapeutics Development ·          CN Bio Innovations Ltd ·          Eiger BioPharmaceuticals Inc ·          F. Hoffmann-La Roche Ltd ·          Globeimmune Inc ·          Merck & Co Inc ·          Replicor Inc Hepatitis D - Therapeutics Assessment ·          Asses...